Orchestra BioMed (OBIO) Misses Q2 EPS by 50c

Orchestra BioMed (NASDAQ: OBIO) reported Q2 EPS of ($0.50). Revenue for the quarter came in at $840 thousand.

For earnings history and earnings-related data on Orchestra BioMed (OBIO) click here.

You May Also Be Interested In

• Morgan Stanley upgrades CDW on stronger AI-driven server demand
• DXC Collects $213,560,494.98 in Landmark IP Theft Case From TCS
• BofA lists top 5 themes driving next $1tn in incremental semi sales